ICU · Cardiovascular
Infective endocarditis in the ICU
Also known as Infective endocarditis (IE) · Bacterial endocarditis · Subacute bacterial endocarditis (SBE) · Duke criteria · Valvular vegetation · Embolic phenomena · Native valve endocarditis · Prosthetic valve endocarditis
Infective endocarditis (IE) is microbial infection of the endocardial surface (usually heart valves). ICU admission for: septic shock, heart failure from valvular destruction, embolic stroke, conduction abnormalities. Diagnosis: modified Duke criteria (blood cultures + echocardiography). Organisms: S. aureus (1 overall — acute, aggressive), viridans streptococci (subacute — dental source, 1 in community-acquired native valve), Enterococcus (genitourinary source), HACEK, culture-negative (Coxiella, Bartonella, fungi — Candida), fungi (Candida — large vegetations, IVDU/prolonged lines). Treatment: prolonged IV antibiotics (4-6 weeks), organism-specific. Empiric: vancomycin + gentamicin + cefepime for severe/septic shock; definitive — penicillin/ceftriaxone for strep, nafcillin/oxacillin (flucloxacillin) for MSSA, vancomycin for MRSA. Surgery indications: heart failure from valvular destruction (1), uncontrolled infection, large mobile vegetation with embolism, perivalvular extension (abscess), prosthetic valve dehiscence.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- S. aureus endocarditis: aggressive course — high risk of valve destruction, emboli, metastatic infection
- New heart failure + murmur = valvular destruction from endocarditis — urgent surgical assessment
- Large (>10mm) mobile vegetation with history of emboli: surgical removal to prevent recurrence
- Persistent bacteraemia >5-7 days despite appropriate antibiotics: surgical intervention
- New heart block in aortic valve IE = perivalvular abscess extending into the septum — surgical emergency
- S. aureus bacteraemia = endocarditis until proven otherwise — ALL patients need echocardiography (TOE preferred)
Meet the patient
A 58-year-old man with a bicuspid aortic valve arrives from the ward with ten days of fever, night sweats and a new diastolic murmur. He is now breathless, his creatinine is climbing, and three sets of blood cultures are growing Streptococcus sanguis. The transthoracic echo shows a 14 mm mobile aortic valve vegetation.[1]
Hold two questions and the whole disease falls into place. Is the infection controlled by drugs alone, or does the valve need to come out? And is there an embolus on its way to his brain? Everything below — the cultures, the echo, the antibiotics, the surgery — serves those two questions.[5]
References24ShowHide
- [1]Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM) Eur Heart J, 2015.PMID 26320109
- [2]Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals From the American Heart Association Circulation, 2015.PMID 26373316
- [3]Chirouze C, Alla F, Fowler VG Jr, et al. Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study Clin Infect Dis, 2015.PMID 25389255
- [4]Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Clin Infect Dis, 2000.PMID 10770721
- [5]Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study Arch Intern Med, 2009.PMID 19273776
- [6]Kang DH Timing of surgery in infective endocarditis Heart, 2015.PMID 26285598
- [7]Pericàs JM, Llopis J, Athan E, et al. Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs J Am Coll Cardiol, 2021.PMID 33538252
- [8]Pericàs JM, Messina JA, Garcia-de-la-Mària C, et al. Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis Clin Microbiol Infect, 2017.PMID 28159672
- [9]Hubert S, Thuny F, Resseguier N, et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort J Am Coll Cardiol, 2013.PMID 23906859
- [10]Lalani T, Kanafani ZA, Chu VH, et al. Prosthetic valve endocarditis due to coagulase-negative staphylococci: findings from the International Collaboration on Endocarditis Merged Database Eur J Clin Microbiol Infect Dis, 2006.PMID 16767483
- [11]Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med, 2012.PMID 22738096
- [12]Mohananey D, Mohadjer A, Pettersson G, et al. Association of Vegetation Size With Embolic Risk in Patients With Infective Endocarditis: A Systematic Review and Meta-analysis. JAMA Intern Med, 2018.PMID 29459947
- [13]Lee A, Mirrett S, Reller LB, et al. Detection of bloodstream infections in adults: how many blood cultures are needed? J Clin Microbiol, 2007.PMID 17881544
- [14]Rybak MJ, Le J, Lodise TP, et al. Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis, 2020.PMID 32658968
- [15]Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med, 2006.PMID 16914701
- [16]Pericas JM, Cervera C, del Rio A, et al. Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Clin Microbiol Infect, 2014.PMID 25040215
- [17]Mirna M, Topf A, Schmutzler L, et al. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials. Clin Res Cardiol, 2022.PMID 34751788
- [18]Boleij A, van Gelder MM, Swinkels DW, et al. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis, 2011.PMID 21960713
- [19]Pasquereau-Kotula E, Martins M, Aymeric L, et al. Significance of Streptococcus gallolyticus subsp. gallolyticus Association With Colorectal Cancer. Front Microbiol, 2018.PMID 29666615
- [20]Wong D, Wong T, Romney M, et al. Comparative effectiveness of β-lactam versus vancomycin empiric therapy in patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia. Ann Clin Microbiol Antimicrob, 2016.PMID 27112143
- [21]Gopal M, Lakhani S, Lee VH Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Unsuspected Infective Endocarditis. J Stroke Cerebrovasc Dis, 2021.PMID 33360518
- [22]Bettencourt S, Ferro JM Acute Ischemic Stroke Treatment in Infective Endocarditis: Systematic Review. J Stroke Cerebrovasc Dis, 2020.PMID 32024600
- [23]Wilson WR Antimicrobial therapy of streptococcal endocarditis. J Antimicrob Chemother, 1987.PMID 3316158
- [24]Mügge A, Daniel WG, Frank G, et al. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol, 1989.PMID 2768712